BRCA1 and ovarian carcinoma: The potential for relatives to make an informed decision to seek their own diagnostic quality BRCA1/2 test and subsequent follow-up (e.g., seek risk-reducing surgery) may arguably be considered a significant benefit of returning BRCA1/2 information to patients who already have ovarian cancer.